Predicting outcomes in acute-on-chronic liver failure
Part of Digestive system clinical trials.
This trial is testing new scoring systems to better predict how patients with acute-on-chronic liver failure will do. It may help doctors make more informed treatment decisions for people with this serious liver condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with acute-on-chronic liver failure (ACLF) using standard criteria.
- You must be admitted to the ICU of the Tropical Medicine and Gastroenterology Department at Al-Rajhi University Hospital.
- You cannot have liver cancer (hepatocellular carcinoma) or advanced cancer outside the liver.
- You cannot be pregnant.
- You must be willing to participate and have complete medical records available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at new blood markers to better predict recovery in patients hospitalized for complications of cirrhosis (like fluid buildup, confusion, or bleeding). You may qualify if you were recently hospitalized for these issues and are expected to go home soon.
This trial compares new scoring tools to predict outcomes in people with liver cirrhosis who are hospitalized for sudden worsening (like fluid buildup, confusion, or bleeding). It aims to find which score works best to guide care.
This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This trial tests a procedure that filters harmful substances from your blood using a special machine. It is for people with severe liver failure (acute-on-chronic) who have signs of inflammation throughout the body.
This study looks at your liver health before and after surgery to predict the risk of “acute-on-chronic liver failure,” which means a sudden worsening of liver function on top of an existing liver condition. If you qualify, your doctors may use study data to better identify who needs closer monitoring after surgery.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.